Xtant Medical Holdings, Inc.

BELGRADE, MT How do I update this listing?

Create Email Alert

Xtant Medical Holdings is based out of Belgrade. Bacterin International Holdings Inc. processes and markets innovative, biologic allografts for transplantation. The Company's products, OsteoSponge(R), OsteoSponge(R) SC and OsteoWrap(R), are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast(R) and OsteoLock(R), which are used in spine surgery, designed to minimize graft back-out, and increase osteoinductivity. Bacterin's latest allograft, OsteoSelect(R) DBM Putty has excellent handling characteristics and is distributed as a sterile product, with osteoinductivity testing completed on every lot after terminal sterilization. Headquartered in Belgrade, Montana, Bacterin operates a 32,000 sq. ft., state-of-the-art, fully compliant and FDA registered facility, equipped with five 'Class 100' clean rooms.Whalewisdom has at least 51 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2021-02-26. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

xtant medical holdings, inc.
664 CRUISER LANE
BELGRADE MT    59714

Business Phone: 406-388-0480
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2021-02-26 D OTHER HEALTH CARE Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 36,250,002 20,000,000 16,250,002
2020-10-05 D OTHER HEALTH CARE Equity 62,882,000 62,882,000 0
2013-06-24 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 4,850,001 4,850,001 0
2011-05-31 D/A BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,500,000 3,027,504 472,496
2011-05-03 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,500,000 1,874,502 1,625,498
2010-07-14 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 17,250,000 7,508,329 9,741,671
2010-07-14 D BIOTECHNOLOGY Equity 45,211,658 45,211,658 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
DANIEL FRANK subscription required
    DIRECTOR
DARREL HOLMES subscription required
    EXECUTIVE OFFICER
GARY SIMON subscription required
    DIRECTOR
GREG JENSEN subscription required
    EXECUTIVE OFFICER
GREG JUDA subscription required
    EXECUTIVE OFFICER
GUY S. COOK subscription required
    EXECUTIVE OFFICER DIRECTOR
JEFFREY PETERS subscription required
    DIRECTOR
JOHN BAKEWELL subscription required
    DIRECTOR
JOHN DEEDRICK subscription required
    DIRECTOR
JOHN GANDALFO subscription required
    EXECUTIVE OFFICER
JOHN P. GANDOLFO subscription required
    EXECUTIVE OFFICER
JON WICKWIRE subscription required
    DIRECTOR
KEN CALLIGAR subscription required
    DIRECTOR
KENT SWANSON subscription required
    DIRECTOR
KEVIN D. BRANDT subscription required
    EXECUTIVE OFFICER
MATTHEW RIZZO subscription required
    DIRECTOR
MICHAEL EGGENBERG subscription required
    DIRECTOR
MICHAEL LOPACH subscription required
    DIRECTOR
MITCHELL T. GODFREY subscription required
    EXECUTIVE OFFICER DIRECTOR
NICHOLAS NAVARRO subscription required
    EXECUTIVE OFFICER
ROBERT MCNAMARA subscription required
    DIRECTOR
SEAN E. BROWNE subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments